← Back to Search

Behavioral Intervention

START Program for ADHD (START Trial)

N/A
Recruiting
Research Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
The child is between 6 and 12 years old
Be younger than 18 years old
Must not have
Participants who are not able to complete study procedures in English
Children under 6 and over 12 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 month
Awards & highlights

Summary

This trial aims to test if a program called START can increase access to treatment for ADHD and improve functioning for children and families. Participants will undergo a psychiatric evaluation before being assigned to either the START program or

Who is the study for?
This trial is for children aged 6-12 with a new or previously untreated ADHD diagnosis, confirmed by the study's psychiatrist. They must be able to understand and follow the study in English. Children treated for other conditions can join if it wasn't for ADHD.
What is being tested?
The START program aims to improve access to ADHD treatment and family functioning. It involves six sessions covering various modules, delivered by trained individuals. The effectiveness will be compared against controls who receive only an informational pamphlet.
What are the potential side effects?
Since START is a non-medical intervention involving educational modules, no direct medical side effects are expected from participation in this program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is between 6 and 12 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot complete study procedures in English.
Select...
My child is either under 6 or over 12 years old.
Select...
My child was diagnosed with ADHD over 3 months ago and has started treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Attention-deficit/hyperactivity disorder (ADHD) Symptoms and Functioning
Attention-deficit/hyperactivity disorder (ADHD) Treatment Utilization
Secondary study objectives
ADHD School Services
ADHD Stages of Engagement Questionnaire
Attention-deficit/hyperactivity disorder (ADHD) Knowledge
+9 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: START InterventionExperimental Treatment1 Intervention
Participants in the experimental group will be part of a 6-module weekly intervention where they will learn more about ADHD and its treatment.
Group II: Educational BrochureActive Control1 Intervention
Participants in the control group will receive an educational brochure by Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD).

Find a Location

Who is running the clinical trial?

Ann & Robert H Lurie Children's Hospital of ChicagoLead Sponsor
264 Previous Clinical Trials
5,193,048 Total Patients Enrolled
2 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
325 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
~26 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top